Deutsche Bank AG Has $3.42 Million Stake in Prestige Consumer Healthcare Inc. $PBH

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Deutsche Bank AG lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 9.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 39,830 shares of the company's stock after selling 3,979 shares during the period. Deutsche Bank AG owned 0.08% of Prestige Consumer Healthcare worth $3,424,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of Montreal Can grew its holdings in shares of Prestige Consumer Healthcare by 15.1% during the fourth quarter. Bank of Montreal Can now owns 7,127 shares of the company's stock valued at $557,000 after purchasing an additional 937 shares during the last quarter. Sterling Capital Management LLC boosted its holdings in shares of Prestige Consumer Healthcare by 837.1% during the fourth quarter. Sterling Capital Management LLC now owns 1,593 shares of the company's stock valued at $124,000 after acquiring an additional 1,423 shares during the period. Barclays PLC grew its position in shares of Prestige Consumer Healthcare by 20.8% during the fourth quarter. Barclays PLC now owns 111,689 shares of the company's stock worth $8,721,000 after acquiring an additional 19,245 shares during the last quarter. Mariner LLC increased its holdings in shares of Prestige Consumer Healthcare by 12.6% in the 4th quarter. Mariner LLC now owns 5,492 shares of the company's stock worth $429,000 after acquiring an additional 615 shares during the period. Finally, XTX Topco Ltd lifted its position in Prestige Consumer Healthcare by 37.2% in the 4th quarter. XTX Topco Ltd now owns 5,017 shares of the company's stock valued at $392,000 after purchasing an additional 1,359 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH traded up $0.4350 during midday trading on Thursday, reaching $65.4850. The company's stock had a trading volume of 546,401 shares, compared to its average volume of 392,521. The company has a market cap of $3.22 billion, a price-to-earnings ratio of 15.37, a price-to-earnings-growth ratio of 2.07 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a one year low of $62.95 and a one year high of $90.04. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55. The company has a 50 day moving average price of $76.03 and a 200 day moving average price of $81.31.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). The business had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The company's quarterly revenue was down 6.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. On average, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have commented on PBH. Canaccord Genuity Group dropped their price target on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Wall Street Zen lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.